Colliers facilitates 36,471 s/f lease renewal for Corbus Pharmaceuticals

Norwood, MA Colliers has facilitated the lease renewal of Corbus Pharmaceuticals at 500 River Ridge Dr. Vice chair Curtis Cole, along with vice president Sean Hannigan and senior vice president Tim Allen of Colliers, represented the tenant in the transaction. JLL, led by Nat Kessler, represented the landlord, River Ridge Limited Partnership.

The renewal encompasses 36,471 s/f within the Class A office property, located in the River Ridge Office Park. Strategically positioned along Rte. 1 with direct access to Rte. 128 and I-95, the location provides Corbus with strong connectivity to Greater Boston’s key business and life sciences corridors. Its accessibility and institutional-quality features continue to attract tenants seeking well-located, high-performance suburban office space. 

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative treatments for cancer and obesity. Driven by a commitment to cutting-edge drug development and scientific excellence, Corbus is dedicated to creating treatments that make a meaningful difference in patients’ lives. The renewal reflects the company’s continued commitment to the Greater Boston market and its focus on sustaining the operational infrastructure needed to support its research programs and pipeline.

“Representing Corbus Pharmaceuticals in this renewal was about making sure the terms and the location worked for their business, today and into the future,” said Hannigan. “500 River Ridge continues to serve as a strong base for their team as they advance their research and operations.”

 “Renewing at 500 River Ridge reflects our confidence in this location as a foundation for our continued work,” said Sean Moran, CFO of Corbus Pharmaceuticals. “Greater Boston’s life sciences ecosystem, combined with our established presence here, positions us well as we move forward with our pipeline and business objectives.”